Negative measurable residual disease (MRD) is associated with significantly better long-term survival in acute myeloid leukaemia (AML), a large meta-analysis has shown. Calculations using data from 81 studies showed a 64% reduction in the risk of death for MRD-negative patients. The findings were consistent across a range of approaches for measuring MRD except for the ...
MRD associated with significantly better long-term survival in AML
By Emma Wilkinson
20 Oct 2020